What You Should Know:

您应该知道：

– Vara, a Berlin, Germany-based provider of AI-enabled breast cancer detection, has announced the successful closure of a $8.9M (€8M EUR) Series B funding round.

–Vara是一家总部位于德国柏林的人工智能乳腺癌检测提供商，已宣布成功结束一轮890万美元（800万欧元）的B系列融资。

Transforming Breast Cancer Screening with AI

用人工智能改造乳腺癌筛查

Vara’s AI-powered software has been shown to significantly outperform average radiologists in detecting breast cancer. Its integration into Germany’s National Breast Cancer Screening Program has benefited over 80,000 women monthly, demonstrating the platform’s potential to transform breast cancer screening and improve patient outcomes..

Vara的人工智能软件已被证明在检测乳腺癌方面明显优于普通放射科医生。它与德国国家乳腺癌筛查计划的整合每月使80000多名女性受益，证明了该平台在改变乳腺癌筛查和改善患者预后方面的潜力。

Key features and benefits of Vara’s AI-powered breast cancer screening platform include:

Vara人工智能乳腺癌筛查平台的主要功能和优势包括：

Increased Cancer Detection: Vara’s AI has significantly improved cancer detection rates, identifying 50% of cancers that radiologists might have missed.Reduced False Positives: The platform minimizes unnecessary recalls, reducing anxiety and costs for patients.Enhanced Efficiency: Streamlines workflows for radiologists, allowing them to focus on suspicious cases..

增加癌症检测：Vara的AI显着提高了癌症检测率，确定了放射科医生可能错过的50%的癌症。减少误报：该平台最大限度地减少了不必要的召回，减少了患者的焦虑和成本。提高效率：简化放射科医生的工作流程，使他们能够专注于可疑病例。

Expanding Reach to Underserved Populations

扩大服务不足人群的覆盖面

Vara is actively expanding its reach to emerging markets, including India, where it has partnered with NM Medical, a leading provider of imaging services. This collaboration aims to improve early breast cancer detection and enhance the standard of preventive care for women in India.

Vara正在积极扩大其对新兴市场的影响力，包括印度，它与领先的成像服务提供商NM Medical合作。这项合作旨在改善早期乳腺癌检测，提高印度妇女的预防保健标准。